221 related articles for article (PubMed ID: 21338841)
1. Yttrium-90 radioembolization for the treatment of primary and metastatic liver tumors.
Sato KT
Semin Roentgenol; 2011 Apr; 46(2):159-65. PubMed ID: 21338841
[No Abstract] [Full Text] [Related]
2. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept.
Gates VL; Esmail AA; Marshall K; Spies S; Salem R
J Nucl Med; 2011 Jan; 52(1):72-6. PubMed ID: 21149493
[TBL] [Abstract][Full Text] [Related]
3. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
Ho S; Lau WY; Leung WT
Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473
[No Abstract] [Full Text] [Related]
4. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
Riaz A; Lewandowski RJ; Kulik L; Salem R
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310
[TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
Dawson LA
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
[No Abstract] [Full Text] [Related]
6. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.
Kennedy A; Coldwell D; Sangro B; Wasan H; Salem R
Am J Clin Oncol; 2012 Feb; 35(1):81-90. PubMed ID: 20938320
[TBL] [Abstract][Full Text] [Related]
7. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
8. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
[TBL] [Abstract][Full Text] [Related]
10. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.
Gates VL; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Nemcek AA; Omary R; Salem R
Future Oncol; 2007 Feb; 3(1):73-81. PubMed ID: 17280504
[TBL] [Abstract][Full Text] [Related]
11. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
[TBL] [Abstract][Full Text] [Related]
12. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
Salem R; Lewandowski RJ; Atassi B; Gordon SC; Gates VL; Barakat O; Sergie Z; Wong CY; Thurston KG
J Vasc Interv Radiol; 2005 Dec; 16(12):1627-39. PubMed ID: 16371529
[TBL] [Abstract][Full Text] [Related]
13. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
Neff R; Abdel-Misih R; Khatri J; Dignazio M; Garcia M; Petrelli N; Wilson P
Cancer Invest; 2008 Mar; 26(2):173-7. PubMed ID: 18259948
[TBL] [Abstract][Full Text] [Related]
14. Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies.
Kennedy AS; Salem R
Cancer J; 2010; 16(2):163-75. PubMed ID: 20404614
[TBL] [Abstract][Full Text] [Related]
15. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
Gaba RC; Lewandowski RJ; Kulik LM; Riaz A; Ibrahim SM; Mulcahy MF; Ryu RK; Sato KT; Gates V; Abecassis MM; Omary RA; Baker TB; Salem R
Ann Surg Oncol; 2009 Jun; 16(6):1587-96. PubMed ID: 19357924
[TBL] [Abstract][Full Text] [Related]
16. State of the art: radiolabeled microspheres treatment for liver malignancies.
Deleporte A; Flamen P; Hendlisz A
Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic (90)Y-microspheres for hepatocellular carcinoma.
Ho S; Lau JW; Leung TW
J Nucl Med; 2001 Oct; 42(10):1587-9. PubMed ID: 11585877
[No Abstract] [Full Text] [Related]
18. Short-term follow-up of radioembolization with yttrium-90 microspheres before liver transplantation: new perspectives in advanced hepatocellular carcinoma.
Ettorre GM; Santoro R; Puoti C; Sciuto R; Carpanese L; Antonini M; Antonucci G; Maini CL; Miglioresi L; Vennarecci G
Transplantation; 2010 Oct; 90(8):930-1. PubMed ID: 20962610
[No Abstract] [Full Text] [Related]
19. Trans-Arterial Radioembolization for Hepatocellular Carcinoma.
Sacco R; Giorgi L; Fornaro L; Bargellini I
Dig Dis; 2015 Sep; 33(5):661-7. PubMed ID: 26398498
[TBL] [Abstract][Full Text] [Related]
20. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
Lewandowski RJ; Riaz A; Ryu RK; Mulcahy MF; Sato KT; Kulik LM; Gates VL; Baker T; Omary R; Salem R
J Vasc Interv Radiol; 2009 Dec; 20(12):1557-63. PubMed ID: 19854068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
